In the assessment of anti-obesity activity, Cu-GO demonstrated the inhibition of pancreatic lipase enzyme activity, showcasing its potential as an anti-obesity agent. This evidence concerns the gene PNLIP and obesity due to melanocortin 4 receptor deficiency.